DIABETIC NEPHROPATHIES
Clinical trials for DIABETIC NEPHROPATHIES explained in plain language.
Never miss a new study
Get alerted when new DIABETIC NEPHROPATHIES trials appear
Sign up with your email to follow new studies for DIABETIC NEPHROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to reduce protein leak in kidney disease patients
Disease control Recruiting nowThis study tests an investigational drug called WAL0921 in adults with certain kidney diseases that cause protein in the urine. About 96 participants will receive either the drug or a placebo as an IV infusion every two weeks for 14 weeks. The goal is to see if the drug is safe a…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
Asthma drug shows promise for diabetic kidney disease in new trial
Disease control Recruiting nowThis study tests whether formoterol, a drug typically used for asthma, can help people with diabetic kidney disease. About 120 adults with type 2 diabetes and moderate kidney damage will be randomly assigned to receive either formoterol plus their usual care or usual care alone. …
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
New oral spray aims to slow kidney failure in millions
Disease control Recruiting nowThis study tests a new oral spray called ACE Reno in 300 adults with chronic kidney disease (CKD) from diabetes, high blood pressure, autoimmune disorders, or other causes. The goal is to see if taking it four times daily for 12 weeks can reduce protein in the urine and help stab…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE4 • Sponsor: Ace Cells Lab Limited • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Could a diabetes drug protect kidneys in type 1 patients? new trial aims to find out.
Disease control Recruiting nowThis study tests whether the drug sotagliflozin can slow kidney function loss in 150 people with type 1 diabetes and moderate to severe kidney disease. Participants will take either the drug or a placebo daily for 3 years, while following a plan to prevent a serious side effect c…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE3 • Sponsor: Alessandro Doria • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Kidney tissue study aims to unlock secrets of diabetes damage
Knowledge-focused Recruiting nowThis study follows 400 adults with diabetes who need a kidney biopsy as part of their care. Researchers collect kidney tissue, blood, urine, and genetic samples to compare people whose kidney function declines rapidly versus slowly. The goal is to find biological markers and pote…
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Scientists dive into kidney tissue to uncover diabetes drug secrets
Knowledge-focused Recruiting nowThis study looks at kidney tissue from adults with diabetic kidney disease who are already having a kidney biopsy or surgery. Researchers want to understand how SGLT2 inhibitors, a common diabetes medicine, change the kidney's molecular makeup. Participants donate a tissue slide,…
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Kidney biopsies may unlock better diagnosis for diabetic kidney disease
Knowledge-focused Recruiting nowThis study aims to better understand and diagnose diabetic kidney disease in people with type 2 diabetes. Researchers will collect kidney tissue and blood, urine, and stool samples from 300 participants to look for molecular and genetic patterns. The goal is to improve diagnosis …
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:55 UTC